{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:09:31Z","timestamp":1791911371661,"version":"4.3.4"},"reference-count":50,"publisher":"BMJ","issue":"24","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2019,7,29]]},"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>Mortality from cardiovascular disease is increased in people with mental health disorders in general and schizophrenia in particular. The causes are multifactorial, but it is known that antipsychotic medication can cause cardiac side-effects beyond the traditional coronary risk factors. Schizophrenia itself is a contributor to an increased risk of cardiovascular mortality via cardiac autonomic dysfunction and a higher prevalence of metabolic syndrome, both contributing to a reduced life expectancy. The pro-arrhythmic impact of traditional antipsychotics, especially via the hERG-potassium channel, has been known for several years. Newer antipsychotics have a reduced pro-arrhythmic profile but might contribute to higher cardiac death rates by worsening the metabolic profile. Clozapine-induced cardiomyopathy, which is dose independent, is a further concern and continuous monitoring of these patients is required. Prophylaxis with angiotensin-converting enzyme inhibitors is currently under review. Overall, management of cardiovascular risk within this population group must be multifaceted and nuanced to allow the most effective treatment of serious mental illness to be conducted within acceptable parameters of cardiovascular risk; some practical measures are presented for the clinical cardiologist.<\/jats:p>","DOI":"10.1136\/heartjnl-2017-312107","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T17:26:13Z","timestamp":1566494773000},"page":"1852-1859","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":62,"title":["Cardiovascular effects of psychotic illnesses and antipsychotic therapy"],"prefix":"10.1136","volume":"105","author":[{"given":"Sandra","family":"Howell","sequence":"first","affiliation":[{"name":"Cardiology, Ealing Hospital, London North West University Healthcare NHS Trust, Middlesex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Yarovova","sequence":"additional","affiliation":[{"name":"Cardiology, Ealing Hospital, London North West University Healthcare NHS Trust, Middlesex, UK"},{"name":"Faculty of Medicine, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Khwanda","sequence":"additional","affiliation":[{"name":"Cardiology, King's College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8034-0037","authenticated-orcid":false,"given":"Stuart D","family":"Rosen","sequence":"additional","affiliation":[{"name":"Cardiology, Ealing Hospital, London North West University Healthcare NHS Trust, Middlesex, UK"},{"name":"Imperial College, National Heart and Lung Institute Division of Cardiovascular Sciences, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"2025092006582411000_105.24.1852.1","unstructured":"Arlington VA . Diagnostic and statistical manual of mental disorders. In: American psychiatric publishing. Fifth ed, 2013: 5\u201325."},{"key":"2025092006582411000_105.24.1852.2","unstructured":"National Institute on mental health. schizophrenia. Available: https:\/\/www.nimh.nih.gov\/health\/statistics\/schizophrenia.shtml"},{"key":"2025092006582411000_105.24.1852.3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/wps.20420","article-title":"Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls","volume":"16","author":"Correll","year":"2017","journal-title":"World Psychiatry"},{"key":"2025092006582411000_105.24.1852.4","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2018.01.011","article-title":"Leading causes of death among decedents with mention of schizophrenia on the death certificates in the United States","volume":"197","author":"Lin","year":"2018","journal-title":"Schizophr Res"},{"key":"2025092006582411000_105.24.1852.5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2012.12050599"},{"key":"2025092006582411000_105.24.1852.6","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.10.1123"},{"key":"2025092006582411000_105.24.1852.7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00406-017-0858-y","article-title":"Increased pericardial adipose tissue and cardiometabolic risk in patients with schizophrenia versus healthy controls","volume":"268","author":"Ruppert","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2025092006582411000_105.24.1852.8","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2018.02.020","article-title":"Chronotropic incompetence of the heart is associated with exercise intolerance in patients with schizophrenia","volume":"197","author":"Herbsleb","year":"2018","journal-title":"Schizophr Res"},{"key":"2025092006582411000_105.24.1852.9","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000088901.24613.b8"},{"key":"2025092006582411000_105.24.1852.10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/acn.12014","article-title":"Cardiac autonomic dysregulation in acute schizophrenia","volume":"25","author":"Chang","year":"2013","journal-title":"Acta Neuropsychiatr"},{"key":"2025092006582411000_105.24.1852.11","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550180055012"},{"key":"2025092006582411000_105.24.1852.12","unstructured":"Djurovic S , Thompson WK , Schork AJ , et al . More links found between schizophrenia and cardiovascular disease."},{"key":"2025092006582411000_105.24.1852.13","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-018-0880-8","article-title":"Qtc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors","volume":"268","author":"Spellmann","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2025092006582411000_105.24.1852.14","doi-asserted-by":"publisher","DOI":"10.1177\/070674370204700106"},{"key":"2025092006582411000_105.24.1852.15","unstructured":"Thomas SH . Qt interval abnormalities and ventricular arrhythmias. adverse drug Reacion adverse drug react Toxicol Rev. Drugs 1994;13"},{"key":"2025092006582411000_105.24.1852.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02035-3"},{"key":"2025092006582411000_105.24.1852.17","unstructured":"Royal College of psychiatrists. the association between antipsychotic drugs and sudden death (College report CR57). Royal College of Psychiatrists 1997."},{"key":"2025092006582411000_105.24.1852.18","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.11.1774"},{"key":"2025092006582411000_105.24.1852.19","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.12.1161"},{"key":"2025092006582411000_105.24.1852.20","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.180.6.515"},{"key":"2025092006582411000_105.24.1852.21","doi-asserted-by":"crossref","unstructured":"Hennessy S , Bilker WB , Knauss JS , et al . Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ 2002;325.doi:10.1136\/bmj.325.7372.1070","DOI":"10.1136\/bmj.325.7372.1070"},{"key":"2025092006582411000_105.24.1852.22","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.164.12.1293","article-title":"Antipsychotics and the risk of sudden cardiac death","volume":"164","author":"Straus","year":"2004","journal-title":"Arch Intern Med"},{"key":"2025092006582411000_105.24.1852.23","doi-asserted-by":"crossref","unstructured":"Huybrechts KF , Gerhard T , Crystal S , et al . Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. Br Med J 2012:344\u2013977.","DOI":"10.1136\/bmj.e977"},{"key":"2025092006582411000_105.24.1852.24","first-page":"k1218","volume-title":"Br Med J (clinical research","volume":"360","author":"Park","year":"2018"},{"key":"2025092006582411000_105.24.1852.25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr368"},{"key":"2025092006582411000_105.24.1852.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2015.03.015"},{"key":"2025092006582411000_105.24.1852.27","first-page":"437","article-title":"Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics","volume":"103","author":"Lin","year":"2004","journal-title":"J. Formos. Med. Assoc"},{"key":"2025092006582411000_105.24.1852.28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/schbul\/sby052","article-title":"Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1-12.5 years","volume":"45","author":"Vermeulen","year":"2019","journal-title":"Schizophr Bull"},{"key":"2025092006582411000_105.24.1852.29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.vph.2017.09.001","article-title":"Effects of psychopharmacological treatment with antipsychotic drugs on the vascular system","volume":"100","author":"Kahl","year":"2018","journal-title":"Vascul Pharmacol"},{"key":"2025092006582411000_105.24.1852.30","doi-asserted-by":"publisher","DOI":"10.1192\/apt.12.1.35"},{"key":"2025092006582411000_105.24.1852.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.210244497"},{"key":"2025092006582411000_105.24.1852.32","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.64.445"},{"key":"2025092006582411000_105.24.1852.33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.711689"},{"key":"2025092006582411000_105.24.1852.34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/cpt.250","article-title":"Sudden cardiac and sudden unexpected death related to antipsychotics: a meta-analysis of observational studies","volume":"99","author":"Salvo","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"2025092006582411000_105.24.1852.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.07.012"},{"key":"2025092006582411000_105.24.1852.36","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20252"},{"key":"2025092006582411000_105.24.1852.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.07.006"},{"key":"2025092006582411000_105.24.1852.38","doi-asserted-by":"crossref","unstructured":"Rosenheck R , Cramer J , Xu W , et al . A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on clozapine in refractory schizophrenia. N Engl J Med 1997;337.doi:10.1056\/NEJM199709183371202","DOI":"10.1056\/NEJM199709183371202"},{"key":"2025092006582411000_105.24.1852.39","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","article-title":"Myocarditis and cardiomyopathy associated with clozapine","volume":"354","author":"Kilian","year":"1999","journal-title":"The Lancet"},{"key":"2025092006582411000_105.24.1852.40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/187152512800388876","article-title":"Does a subclinical cardiotoxic effect of clozapine exist? results from a follow-up pilot study","volume":"10","author":"Rostagno","year":"2012","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"2025092006582411000_105.24.1852.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1614.2004.01481.x"},{"key":"2025092006582411000_105.24.1852.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00434-5"},{"key":"2025092006582411000_105.24.1852.43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5694\/j.1326-5377.2009.tb02345.x","article-title":"Clozapine-Induced cardiotoxicity: a clinical update","volume":"190","author":"Layland","year":"2009","journal-title":"Med J Austral"},{"key":"2025092006582411000_105.24.1852.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.07.103"},{"key":"2025092006582411000_105.24.1852.45","doi-asserted-by":"crossref","unstructured":"Correll CU , Robinson DG , Schooler NR , et al . Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. JAMA psychiatry 2014;71.","DOI":"10.1001\/jamapsychiatry.2014.1314"},{"key":"2025092006582411000_105.24.1852.46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eurpsy.2018.07.004","article-title":"Epa guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and position statement from the European psychiatric association (EPA), supported by the International organization of physical therapists in mental health (IOPTMH)","volume":"54","author":"Stubbs","year":"2018","journal-title":"Eur Psychiatry"},{"key":"2025092006582411000_105.24.1852.47","doi-asserted-by":"publisher","DOI":"10.3109\/00048674.2011.572852"},{"key":"2025092006582411000_105.24.1852.48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cbi.2014.03.012","article-title":"Protective effect of captopril against clozapine-induced myocarditis in rats: role of oxidative stress, proinflammatory cytokines and DNA damage","volume":"216","author":"Abdel-Wahab","year":"2014","journal-title":"Chem Biol Interact"},{"key":"2025092006582411000_105.24.1852.49","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.mjt.0000212704.79248.3d","article-title":"Razminia M1, Salem Y, Devaki S, Shah N, Khosla S. clozapine induced myopericarditis: early recognition improves clinical outcome","volume":"13","year":"2006","journal-title":"Am J Ther"},{"key":"2025092006582411000_105.24.1852.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2009.01.005"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2017-312107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T13:58:36Z","timestamp":1758376716000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2017-312107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":50,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2019,11,29]]},"published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1136\/heartjnl-2017-312107"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2017-312107","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]}}}